This effect was also observed in vivo, as mice injected with cathepsin L knockdown breast cancer cells or treated with a selective cathepsin L inhibitor exhibited significantly smaller tumors compared to the controls with functional cathepsin L [101, 103, 105]. This evidence concerns the gene CTSL and breast carcinoma.